|
| Press Releases |
|
 |
|
| Friday, August 15, 2025 |
|
|
OrbusNeich Records Growth in 2025 Interim Results, Revenue and Net Profit Reach US$83.6 Million and US$19.8 Million Respectively |
| OrbusNeich Medical Group Holdings Limited ('OrbusNeich' or the 'Group'; stock code: 6929), a multinational medical device company specializing in interventional devices for percutaneous coronary intervention ('PCI') and percutaneous transluminal angioplasty ('PTA') procedures, today announced its interim results for the six months ended June 30, 2025 (the 'Period'), reporting growth in both revenue and net profit despite an uncertain macroeconomic landscape. more info >> |
|
| Friday, March 7, 2025 |
|
|
OrbusNeich Achieves Fourth Consecutive Year of Revenue Growth with Record High Revenue of US$164.1 Million and Net Profit of US$39.7 Million |
| OrbusNeich Medical Group Holdings Limited ('OrbusNeich' or the 'Group'; stock code: 6929), a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention ('PCI') and percutaneous transluminal angioplasty ('PTA') procedures, today announced its annual results for the year ended December 31, 2024 (the 'Year'), reporting record-high revenue and healthy net profit despite the challenging business landscape. more info >> |
|
| Friday, August 16, 2024 |
|
|
OrbusNeich Records Net Profit of US$18.8 Million for the First Half of 2024 |
| OrbusNeich Medical Group Holdings Limited ('OrbusNeich' or the 'Group'; stock code: 6929), a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention ('PCI') and percutaneous transluminal angioplasty ('PTA') procedures, today announced its interim results for the six months ended June 30, 2024 (the 'Reporting Period), with revenue and profit for the period attributable to owners of the Company maintained at US$78.9 million and US$18.8 million respectively despite various market challenges. more info >> |
|
| Wednesday, April 24, 2024 |
|
|
OrbusNeich's Joint Venture Kicks Off TricValve Clinical Trial in Mainland China |
| OrbusNeich Medical Group Holdings Limited announced today that the Group's joint venture OrbusNeich P+F Company Limited ("ON P&F") has commenced the clinical trial for the TricValve Transcatheter Bicaval Valve System ("TricValve"), to treat patients with hemodynamically relevant tricuspid insufficiency and caval reflux, on April 22, 2024 across Mainland China. more info >> |
|
| Thursday, March 7, 2024 |
|
|
OrbusNeich Achieves Record-High Revenue and Net Profit of US$154 Million and US$45.1 Million Respectively, Recommends Final Dividend Payment of HK10 cents per Share |
| OrbusNeich Medical Group Holdings Limited ("OrbusNeich" or the "Group"; stock code: 6929), a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures more info >> |
|
| Monday, November 27, 2023 |
|
|
OrbusNeich Acquires 84% Stake in Indonesian Distributor PT Revass for Approximately US$15 Million |
| OrbusNeich Medical Group Holdings Limited ("OrbusNeich", 6929.HK), a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures more info >> |
|
| Thursday, November 23, 2023 |
|
|
OrbusNeich Adds Drug-eluting Balloons in Product Portfolio Through Acquisition of Eucatech AG |
| OrbusNeich Medical Group Holdings Limited ("OrbusNeich" or the "Group"; stock code: 6929), a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures more info >> |
|
| Thursday, August 17, 2023 |
|
|
OrbusNeich FY2023 Interim Net Profit Triples to US$25.2 Million, Total Revenue Increases by 18.2% to US$81.4 Million |
| OrbusNeich Medical Group Holdings Limited ("OrbusNeich" or the "Group"; stock code: 6929), a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures, today announced its interim results for the six months ended 30 June 2023, reporting growth in both revenue and net profit. more info >> |
|
| Monday, May 8, 2023 |
|
|
OrbusNeich Kicks Off Clinical Study of Scoreflex TRIO, Completing China's First PCI Intervention Procedure with High-Pressure, Three-wire Scoring Balloon Dilatation Catheter |
| OrbusNeich Medical Group Holdings Limited ("OrbusNeich" or the "Group"; stock code: 6929), a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures more info >> |
|
| Tuesday, March 28, 2023 |
|
|
OrbusNeich Plans to Set up Its Largest R&D and Production Base in Fuchun Bay New Town, Hangzhou, the PRC |
| OrbusNeich Medical (Zhejiang) Company Limited ("OrbusNeich Zhejiang"), a wholly-owned subsidiary of OrbusNeich Medical Group Holdings Limited ("OrbusNeich" or the "Group"; stock code: 6929), a major global medical device manufacturer specialized in interventional instruments for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
 |
Global Media First Drive of G700: A Comprehensive Validation of GAIA Hybrid Off-Road Architecture
Oct 24, 2025 21:00 HKT/SGT
|
|
|
Scandium International Mining Announces Exercise of Options by Chief Executive Officer and Chief Financial Officer
Oct 24, 2025 19:39 HKT/SGT
|
|
|
Trio AI and HTHK Sign MOU to Expand 5G-Powered Smart Robotics in Property Management, Construction, and Public Services Organizations, Advancing Hong Kong's Smart City Vision
Oct 24, 2025 18:07 HKT/SGT
|
|
|
FIG, Fujitsu, Acer Medical collaborate to develop health-promoting insurance concept to support preventative care in aging societies
Oct 24, 2025 16:52 JST
|
|
|
SHARP unveils the new "LDK+" EV concept model at Japan Mobility Show 2025
Oct 24, 2025 16:18 JST
|
|
|
Mitsubishi Shipbuilding Holds Christening and Launch Ceremony in Shimonoseki for Training Ship WAKASHIO MARU Built for National Institute of Technology, Toyama College
Oct 23, 2025 0:29 JST
|
|
|
Mazda and Nippon Steel Strengthen Collaboration
Oct 23, 2025 23:57 JST
|
|
|
Immersive Museum "THE MOVEUM YOKOHAMA by TOYOTA GROUP" to Open on December 20, 2025
Oct 23, 2025 23:27 JST
|
|
|
PacificLight Appoints a Consortium of Mitsubishi Power and Jurong Engineering Limited to build 670 MW CCGT Power Plant in Singapore
Oct 23, 2025 23:12 JST
|
|
|
Doubleview Gold Corp Announces 320-Meter Eastward Extension at the Hat Polymetallic Deposit, Expanding Mineralized Volume and Remaining Open
Oct 23, 2025 20:59 HKT/SGT
|
|
|
U.S. Polo Assn. Wins Gold and Silver Stevie Awards at the 2025 International Business Awards in Lisbon, Portugal
Oct 23, 2025 19:00 HKT/SGT
|
|
|
CITIC Telecom CPC Garners CAHK STAR Award 2025 Again
Oct 23, 2025 16:02 HKT/SGT
|
|
|
TOHO and Haneda Airport Team Up for Godzilla Global Project Launch
Oct 23, 2025 16:00 HKT/SGT
|
|
|
Blockpass & BAS Secure Binance's BNB Chain with Reusable, Verifiable Credentials
Oct 23, 2025 13:00 HKT/SGT
|
|
|
Japan IT Week Autumn 2025: NIPA Expands South Korea's Presence in Japan's AI and Deep Tech Ecosystem
Oct 23, 2025 12:30 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
 |
 |
 |
|
|